Skip to search formSkip to main contentSkip to account menu

fantofarone

Known as: 2-isopropyl-1-((4-(3-(N-methyl-N-(3,4-dimethoxy-beta-phenethyl)amino)propoxy)benzenesulfonyl))indolizine, Benzeneethanamine, 3,4-dimethoxy-N-methyl-N-(3-(4-((2-(1-methylethyl)-1-indolizinyl)sulfonyl)phenoxy)propyl)- 
National Institutes of Health

Related topics

Related topics

6 relations

Broader (5)

Calcium Channel BlockersEnzyme InhibitorsIndolizinesPhenethylamines

Narrower (1)

SR 33557

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
SR33805, a Ca2+ antagonist with length‐dependent Ca2+‐sensitizing properties in cardiac myocytes
This study examined the effects of SR33805, a fantofarone derivative with reported strong Ca2+ ‐antagonistic properties, on the… 
1999
1999
Pharmacokinetic-pharmacodynamic model for fantofarone cardiac and brachial haemodynamic effects in healthy volunteers.
AIMS To investigate the pharmacokinetics of SR 33671, the main active metabolite of the calcium antagonist fantofarone, and the… 
1998
1998
Synergy between two calcium channel blockers, verapamil and fantofarone (SR33557), in reversing chloroquine resistance in Plasmodium falciparum.
1997
1997
Safety and Efficacy of Monotherapy with Fantofarone, a Novel Calcium Channel Antagonist, in Patients with Chronic Stable Angina Pectoris
Fantofarone is a calcium channel antagonist of a class (sulfone indolizine) that is structurally different from the existing… 
1995
1995
Effect of SR 33805 on arterial smooth muscle cell proliferation and neointima formation following vascular injury.
1995
1995
Vascular calcium overload produced by vitamin D3, in rats. Effect of treatment with SR 33805, a novel calcium entry blocker.
1994
1994
Binding of fantofarone, a novel Ca2+ antagonist, to serum albumin: a fluorescence study.
Using the fluorescent properties of fantofarone, we have studied the interactions between this novel calcium entry blocker and… 
1994
1994
Characterization of the binding of [3H]SR 33805 to the slow Ca2+ channel in rat heart sarcolemmal membrane.
1994
1994
Fantofarone (SR33557): effects on myocardial oxygen consumption and coronary blood flow.
We have investigated the effects of a novel calcium antagonist, fantofarone (SR 33557) on myocardial oxygen consumption (MO2C… 
1993
1993
In vitro characterization of a novel Ca2+ entry blocker: SR 33805.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)